Researchers at Purdue University have developed an alternative method of treatment that allows for custom molding of implants, increased porosity between particles for global cell delivery, and relatively small cartilage thicknesses for promoted cell infiltration. This technology uses native tissue .....
[Detail]
This technology marries the Recombinant Human Tissue Factor (TF) with Membrane Scaffold Protein (MSP) NanodiscsTM, resulting in an efficient and easy to administer blood coagulation agent that has the potential for major advances in medicine.
[Detail]
Changes in the normal pattern of specific oxygen distribution is indicative of abnormalities or pathology, for example local vasoconstriction or insufficiency of oxygen delivery to the blood.
[Detail]
